Adiponectin is a novel endogenous insulin sensitizer, secreted by mature adipocytes.
Circulating levels of adiponectin are inversely associated with obesity and insulin …

Adiponectin appears to be an important modulator for metabolic and vascular diseases. A
case-controlled study was designed to measure plasma adiponectin levels and investigate …

Obesity is a worldwide pandemic health issue. Obesity is associated with the pathogenesis
of type 2 diabetes, hypertension, dyslipidemia, cardiovascular diseases, cancer, and kidney …

Adiponectin has antiatherogenic properties and attenuates endothelial inflammatory
responses. CD146 is a novel cell adhesion molecule localized at the endothelial junction. In …

Chronic kidney disease is a major public health problem and characterized by a progressive
loss in renal function over a period of months or years as defined by structural or functional …

Adiponectin circulates in blood in multiple isoforms. High molecular weight (HMW)
adiponectin is thought to be most biologically active and promotes glucose uptake, insulin …

Several studies found that adiponectin, an adipokine withstands atherosclerosis in vivo, is
significantly increased in subjects with diabetic nephropathy (DN), but its clinical meaning …

The metabolic burden caused by hyperglycemia can result in direct and immediate
metabolic injuries, such as oxidative stress and tissue inflammation, in the kidney …